Esperion Therapeutics, Inc (ESPR) Reports Q4 Earnings
**BREAKING: Esperion Therapeutics Reports Q4 2025 Results**
Breaking market news, earnings coverage, and in-depth interviews with industry leaders.
**BREAKING: Esperion Therapeutics Reports Q4 2025 Results**
Kohl's Corporation (NYQ:KSS), the omnichannel retailer operating department stores across the United States, reported fourth quarter 2025 results...
**BREAKING: Apyx Medical Corporation Reports Q4 2025 Results**
Legend Biotech posts $0.01 adjusted EPS in Q4 2025, turning profitable on 64% revenue growth to $306.3M as...
ABM Industries Inc (ABM) reported Q1 2026 gaap earnings of $0.83 per share, missing the $0.87 consensus estimate...
Nio Inc (NIO) delivered Q4 2025 gaap earnings of $0.29 per share, surpassing analysts' $0.05 forecast (beat by...
Priority Technology Holdings, Inc (NASDAQ:PRTH) reported fourth quarter 2025 financial results. Q4 2025 adjusted earnings at Priority Technology...
Q32 Bio Inc. (QTTB) reported Q4 2025 adjusted earnings of $3.65 per share. No consensus estimate was available...
BioNTech reports Q4 loss of $0.33/share on revenue of $907.4M, down 23.8% year-over-year as vaccine demand normalizes.
Cullinan Therapeutics posts $0.73 per share loss in Q4 2025, matching year-ago results as the pre-revenue biotech maintains...
**Tenax Therapeutics Reports Q4 2025 Results**